
Mohamed Barakat
Examiner (ID: 11478, Phone: (571)270-3696 , Office: P/2689 )
| Most Active Art Unit | 2689 |
| Art Unit(s) | 2689, 2681, 2612 |
| Total Applications | 995 |
| Issued Applications | 735 |
| Pending Applications | 77 |
| Abandoned Applications | 216 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6459522
[patent_doc_number] => 20100190172
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-07-29
[patent_title] => 'GENETIC POLYMORPHISMS ASSOCIATED WITH CARDIOVASCULAR DISORDERS AND DRUG RESPONSE, METHODS OF DETECTION AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/683099
[patent_app_country] => US
[patent_app_date] => 2010-01-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 57303
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0190/20100190172.pdf
[firstpage_image] =>[orig_patent_app_number] => 12683099
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/683099 | GENETIC POLYMORPHISMS ASSOCIATED WITH CARDIOVASCULAR DISORDERS AND DRUG RESPONSE, METHODS OF DETECTION AND USES THEREOF | Jan 5, 2010 | Abandoned |
Array
(
[id] => 6317093
[patent_doc_number] => 20100112593
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-05-06
[patent_title] => 'Method of Predicting the Clinical Response to Chemotherapeutic Treatment with Alkylating Agents'
[patent_app_type] => utility
[patent_app_number] => 12/683379
[patent_app_country] => US
[patent_app_date] => 2010-01-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 11646
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0112/20100112593.pdf
[firstpage_image] =>[orig_patent_app_number] => 12683379
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/683379 | Method of Predicting the Clinical Response to Chemotherapeutic Treatment with Alkylating Agents | Jan 5, 2010 | Abandoned |
Array
(
[id] => 6509888
[patent_doc_number] => 20100261173
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-10-14
[patent_title] => 'Identification Of Fat And Lean Phenotypes In Chickens Using Molecular Markers'
[patent_app_type] => utility
[patent_app_number] => 12/652807
[patent_app_country] => US
[patent_app_date] => 2010-01-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 10068
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0261/20100261173.pdf
[firstpage_image] =>[orig_patent_app_number] => 12652807
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/652807 | Identification Of Fat And Lean Phenotypes In Chickens Using Molecular Markers | Jan 5, 2010 | Abandoned |
Array
(
[id] => 6447194
[patent_doc_number] => 20100105066
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-04-29
[patent_title] => 'Tissue Rejection'
[patent_app_type] => utility
[patent_app_number] => 12/652537
[patent_app_country] => US
[patent_app_date] => 2010-01-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 56977
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0105/20100105066.pdf
[firstpage_image] =>[orig_patent_app_number] => 12652537
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/652537 | Tissue Rejection | Jan 4, 2010 | Abandoned |
| 11/921098 | Methods of diagnosing and treating cancer by detection of chromosomal abnormalities | Dec 20, 2009 | Abandoned |
Array
(
[id] => 7656776
[patent_doc_number] => 20110306045
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-12-15
[patent_title] => 'Method for Confirming a Diagnosis of Rolandic Epilepsy'
[patent_app_type] => utility
[patent_app_number] => 13/141044
[patent_app_country] => US
[patent_app_date] => 2009-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 12265
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0306/20110306045.pdf
[firstpage_image] =>[orig_patent_app_number] => 13141044
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/141044 | Method for Confirming a Diagnosis of Rolandic Epilepsy | Dec 20, 2009 | Abandoned |
Array
(
[id] => 6294497
[patent_doc_number] => 20100240037
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-09-23
[patent_title] => 'IDENTIFICATION OF MARKERS IN ESOPHAGEAL CANCER, COLON CANCER, HEAD AND NECK CANCER, AND MELANOMA'
[patent_app_type] => utility
[patent_app_number] => 12/637862
[patent_app_country] => US
[patent_app_date] => 2009-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 33
[patent_figures_cnt] => 33
[patent_no_of_words] => 12796
[patent_no_of_claims] => 44
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0240/20100240037.pdf
[firstpage_image] =>[orig_patent_app_number] => 12637862
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/637862 | IDENTIFICATION OF MARKERS IN ESOPHAGEAL CANCER, COLON CANCER, HEAD AND NECK CANCER, AND MELANOMA | Dec 14, 2009 | Abandoned |
Array
(
[id] => 6343753
[patent_doc_number] => 20100248232
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-09-30
[patent_title] => 'METHODS FOR DETERMINING THE PRESENCE OR ABSENCE OF ELITE EVENT MS-BN1 IN BRASSICA PLANT MATERIAL'
[patent_app_type] => utility
[patent_app_number] => 12/635215
[patent_app_country] => US
[patent_app_date] => 2009-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 17309
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0248/20100248232.pdf
[firstpage_image] =>[orig_patent_app_number] => 12635215
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/635215 | Methods for determining the presence or absence of elite event RF-BN1 in Brassica plant material | Dec 9, 2009 | Issued |
Array
(
[id] => 6247124
[patent_doc_number] => 20100136565
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-06-03
[patent_title] => 'Compositions and Methods for Diagnosing Autism'
[patent_app_type] => utility
[patent_app_number] => 12/629474
[patent_app_country] => US
[patent_app_date] => 2009-12-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28315
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0136/20100136565.pdf
[firstpage_image] =>[orig_patent_app_number] => 12629474
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/629474 | Compositions and Methods for Diagnosing Autism | Dec 1, 2009 | Abandoned |
Array
(
[id] => 6374523
[patent_doc_number] => 20100081145
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-04-01
[patent_title] => 'Detecting Prostate Cancer'
[patent_app_type] => utility
[patent_app_number] => 12/628764
[patent_app_country] => US
[patent_app_date] => 2009-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9126
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0081/20100081145.pdf
[firstpage_image] =>[orig_patent_app_number] => 12628764
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/628764 | Detecting Prostate Cancer | Nov 30, 2009 | Abandoned |
Array
(
[id] => 7732342
[patent_doc_number] => 20120015357
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-01-19
[patent_title] => 'PREDICTION OF LIPID-METABOTYPE-RELATED PHYSIOLOGICAL SUSCEPTIBILITIES'
[patent_app_type] => utility
[patent_app_number] => 13/131242
[patent_app_country] => US
[patent_app_date] => 2009-11-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 31888
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0015/20120015357.pdf
[firstpage_image] =>[orig_patent_app_number] => 13131242
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/131242 | PREDICTION OF LIPID-METABOTYPE-RELATED PHYSIOLOGICAL SUSCEPTIBILITIES | Nov 26, 2009 | Abandoned |
Array
(
[id] => 7697119
[patent_doc_number] => 20110229471
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-09-22
[patent_title] => 'METHODS OF DETERMINING RESPONSIVENESS TO ANTI-TNF ALPHA THERAPY IN INFLAMMATORY BOWEL DISEASE'
[patent_app_type] => utility
[patent_app_number] => 13/130998
[patent_app_country] => US
[patent_app_date] => 2009-11-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 20264
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0229/20110229471.pdf
[firstpage_image] =>[orig_patent_app_number] => 13130998
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/130998 | METHODS OF DETERMINING RESPONSIVENESS TO ANTI-TNF ALPHA THERAPY IN INFLAMMATORY BOWEL DISEASE | Nov 24, 2009 | Abandoned |
Array
(
[id] => 7710966
[patent_doc_number] => 20120003642
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-01-05
[patent_title] => 'OLIGONUCLEOTIDES AND METHODS FOR DETERMINING SUSCEPTIBILITY TO SOFT TISSUE INJURIES'
[patent_app_type] => utility
[patent_app_number] => 13/127668
[patent_app_country] => US
[patent_app_date] => 2009-11-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 7630
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13127668
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/127668 | OLIGONUCLEOTIDES AND METHODS FOR DETERMINING SUSCEPTIBILITY TO SOFT TISSUE INJURIES | Nov 3, 2009 | Abandoned |
Array
(
[id] => 6220614
[patent_doc_number] => 20100055709
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-03-04
[patent_title] => 'Tubulin Mutation Diagnostic'
[patent_app_type] => utility
[patent_app_number] => 12/610400
[patent_app_country] => US
[patent_app_date] => 2009-11-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 8424
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0055/20100055709.pdf
[firstpage_image] =>[orig_patent_app_number] => 12610400
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/610400 | Tubulin Mutation Diagnostic | Nov 1, 2009 | Abandoned |
Array
(
[id] => 7683778
[patent_doc_number] => 20100122363
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-05-13
[patent_title] => 'Certain human genomic DNA associated with total red-green colorblindness'
[patent_app_type] => utility
[patent_app_number] => 12/588704
[patent_app_country] => US
[patent_app_date] => 2009-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 11753
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0122/20100122363.pdf
[firstpage_image] =>[orig_patent_app_number] => 12588704
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/588704 | Certain human genomic DNA associated with total red-green colorblindness | Oct 25, 2009 | Abandoned |
Array
(
[id] => 6595061
[patent_doc_number] => 20100062447
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-03-11
[patent_title] => 'Methods for Identifying Cancer Risk'
[patent_app_type] => utility
[patent_app_number] => 12/606070
[patent_app_country] => US
[patent_app_date] => 2009-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 12726
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0062/20100062447.pdf
[firstpage_image] =>[orig_patent_app_number] => 12606070
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/606070 | Methods for Identifying Cancer Risk | Oct 25, 2009 | Abandoned |
Array
(
[id] => 8884081
[patent_doc_number] => 20130157265
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-06-20
[patent_title] => 'COMPOSITION, METHOD AND KIT FOR DETECTING BACTERIA BY MEANS OF SEQUENCING'
[patent_app_type] => utility
[patent_app_number] => 13/502395
[patent_app_country] => US
[patent_app_date] => 2009-10-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 11012
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13502395
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/502395 | COMPOSITION, METHOD AND KIT FOR DETECTING BACTERIA BY MEANS OF SEQUENCING | Oct 21, 2009 | Abandoned |
Array
(
[id] => 7568088
[patent_doc_number] => 20110288151
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-11-24
[patent_title] => 'METHODS OF CHARACTERIZING BREAST CANCER AND IDENTIFYING TREATMENTS FOR SAME'
[patent_app_type] => utility
[patent_app_number] => 13/122811
[patent_app_country] => US
[patent_app_date] => 2009-10-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 11558
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0288/20110288151.pdf
[firstpage_image] =>[orig_patent_app_number] => 13122811
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/122811 | METHODS OF CHARACTERIZING BREAST CANCER AND IDENTIFYING TREATMENTS FOR SAME | Oct 5, 2009 | Abandoned |
Array
(
[id] => 6119161
[patent_doc_number] => 20110076677
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-03-31
[patent_title] => 'METHOD FOR DETECTING SINGLE NUCLEOTIDE POLYMORPHISMS'
[patent_app_type] => utility
[patent_app_number] => 12/569648
[patent_app_country] => US
[patent_app_date] => 2009-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 17017
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0076/20110076677.pdf
[firstpage_image] =>[orig_patent_app_number] => 12569648
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/569648 | Method for detecting single nucleotide polymorphisms | Sep 28, 2009 | Issued |
Array
(
[id] => 6229665
[patent_doc_number] => 20100184040
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-07-22
[patent_title] => 'COMPOSITIONS AND METHODS FOR DETERMINING LIKELIHOOD OF TWINNING'
[patent_app_type] => utility
[patent_app_number] => 12/568334
[patent_app_country] => US
[patent_app_date] => 2009-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 27714
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0184/20100184040.pdf
[firstpage_image] =>[orig_patent_app_number] => 12568334
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/568334 | COMPOSITIONS AND METHODS FOR DETERMINING LIKELIHOOD OF TWINNING | Sep 27, 2009 | Abandoned |